Clinical Characteristic and Management of Acquired Uterine Arteriovenous Malformation
- PMID: 30334536
- PMCID: PMC6202597
- DOI: 10.4103/0366-6999.243570
Clinical Characteristic and Management of Acquired Uterine Arteriovenous Malformation
Conflict of interest statement
There are no conflicts of interest
Figures
References
-
- Picel AC, Koo SJ, Roberts AC. Transcatheter arterial embolization with n-butyl cyanoacrylate for the treatment of acquired uterine vascular malformations. Cardiovasc Intervent Radiol. 2016;39:1170–6. doi: 10.1007/s00270-016-1328-z. - PubMed
-
- Fleming H, Ostor AG, Pickel H, Fortune, DW Arteriovenous malformations of the uterus. Obstet Gynecol. 1989;73:209–14. - PubMed
-
- Timor-Tritsch IE, Haynes MC, Monteagudo A, Khatib N, Kovács S. Ultrasound diagnosis and management of acquired uterine enhanced myometrial vascularity/arteriovenous malformations. Am J Obstet Gynecol. 2016;214:731.e1–731.e10. doi: 10.1016/j.ajog.2015.12.024. - PubMed
-
- Szpera-Goździewicz A, Gruca-Stryjak K, Bręborowicz GH, Ropacka-Lesiak M. Uterine arteriovenous malformation – Diagnosis and management. Ginekol Pol. 2018;89:276–9. doi: 10.5603/GP.a2018.0047. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
